Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Quick Stats
Jan 30, 202650.0
AI Score
HOLD0.7
Volume Ratio
Mar 30, 2026
Next Earnings
13
+ve Days (30d)
13
-ve Days (30d)
LUCD Stock Summary
Last updated Jan 30, 2026
LUCD is currently trading at $1.19, positioned above its 200-day moving average of $1.15, indicating a long-term uptrend. The stock has a 52-week range of $0.885 to $1.8.
Technical Analysis: The 50-day moving average stands at $1.12, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 52.763, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.544, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates LUCD at 50.0/100 with a HOLD recommendation.
LUCD (Lucid Diagnostics Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 52.763 |
| CMF (20) | -0.544 |
| ROC (10) | -4.8 |
| ADX (14) | 43.494 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.013 |
| AROONOSC (14) | -7.143 |
| WILLAMS %R (14) | -75.833 |
| MFI (14) | 88.787 |
LUCD Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
LUCD Price vs Max Options Open Interest
LUCD Max Change In Options Open Interest
LUCD Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LUCD Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LUCD Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
LUCD Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Lucid Diagnostics Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
LUCD Moving Averages Analysis
Lucid Diagnostics Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
LUCD (Lucid Diagnostics Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.17 |
| 20 | 1.18 |
| 30 | 1.15 |
| 50 | 1.12 |
| 100 | 1.12 |
| 200 | 1.15 |
LUCD Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 149.5 million |
| Earnings/Share ($) | -0.77 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.4333 |
| EPS Estimate Next Year ($) | -0.3033 |
| WallStreet Target Price ($) | 3.7917 |
| Most Recent Quarter |